Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Mesenchymal Stem Cells with eNOS Over-Expression Enhance Cardiac Repair in Rats with Myocardial Infarction.

Chen L, Zhang Y, Tao L, Yang Z, Wang L.

Cardiovasc Drugs Ther. 2017 Feb;31(1):9-18. doi: 10.1007/s10557-016-6704-z.

PMID:
27913896
2.

Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.

Huang J, Zhang Z, Guo J, Ni A, Deb A, Zhang L, Mirotsou M, Pratt RE, Dzau VJ.

Circ Res. 2010 Jun 11;106(11):1753-62. doi: 10.1161/CIRCRESAHA.109.196030. Epub 2010 Apr 8.

3.

Transplantation of mesenchymal stem cells overexpressing IL10 attenuates cardiac impairments in rats with myocardial infarction.

Meng X, Li J, Yu M, Yang J, Zheng M, Zhang J, Sun C, Liang H, Liu L.

J Cell Physiol. 2018 Jan;233(1):587-595. doi: 10.1002/jcp.25919. Epub 2017 May 19.

PMID:
28322445
4.

Minicircle DNA-mediated endothelial nitric oxide synthase gene transfer enhances angiogenic responses of bone marrow-derived mesenchymal stem cells.

Bandara N, Gurusinghe S, Chen H, Chen S, Wang LX, Lim SY, Strappe P.

Stem Cell Res Ther. 2016 Apr 1;7:48. doi: 10.1186/s13287-016-0307-2.

5.

Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.

Tang J, Wang J, Yang J, Kong X, Zheng F, Guo L, Zhang L, Huang Y.

Eur J Cardiothorac Surg. 2009 Oct;36(4):644-50. doi: 10.1016/j.ejcts.2009.04.052. Epub 2009 Jun 12.

PMID:
19524448
6.

Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction.

Huang B, Qian J, Ma J, Huang Z, Shen Y, Chen X, Sun A, Ge J, Chen H.

Stem Cell Res Ther. 2014 Feb 7;5(1):22. doi: 10.1186/scrt410.

8.

Atorvastatin enhance efficacy of mesenchymal stem cells treatment for swine myocardial infarction via activation of nitric oxide synthase.

Song L, Yang YJ, Dong QT, Qian HY, Gao RL, Qiao SB, Shen R, He ZX, Lu MJ, Zhao SH, Geng YJ, Gersh BJ.

PLoS One. 2013 May 31;8(5):e65702. doi: 10.1371/journal.pone.0065702. Print 2013.

9.

Overexpression of Nitric Oxide Synthase Restores Circulating Angiogenic Cell Function in Patients With Coronary Artery Disease: Implications for Autologous Cell Therapy for Myocardial Infarction.

Chen Q, Varga M, Wang X, Haddad DJ, An S, Medzikovic L, Derakhshandeh R, Kostyushev DS, Zhang Y, Clifford BT, Luu E, Danforth OM, Rafikov R, Gong W, Black SM, Suchkov SV, Fineman JR, Heiss C, Aschbacher K, Yeghiazarians Y, Springer ML.

J Am Heart Assoc. 2016 Jan 6;5(1). pii: e002257. doi: 10.1161/JAHA.115.002257.

10.

Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension.

Kanki-Horimoto S, Horimoto H, Mieno S, Kishida K, Watanabe F, Furuya E, Katsumata T.

Circulation. 2006 Jul 4;114(1 Suppl):I181-5.

PMID:
16820570
11.

Deterioration of cardiac function after acute myocardial infarction is prevented by transplantation of modified endothelial progenitor cells overexpressing endothelial NO synthases.

Chen X, Gu M, Zhao X, Zheng X, Qin Y, You X.

Cell Physiol Biochem. 2013;31(2-3):355-65. doi: 10.1159/000343373. Epub 2013 Mar 1.

12.

Synthetic vascular prosthesis impregnated with mesenchymal stem cells overexpressing endothelial nitric oxide synthase.

Kanki-Horimoto S, Horimoto H, Mieno S, Kishida K, Watanabe F, Furuya E, Katsumata T.

Circulation. 2006 Jul 4;114(1 Suppl):I327-30.

PMID:
16820594
13.

Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance.

Zeng B, Chen H, Zhu C, Ren X, Lin G, Cao F.

Eur J Cardiothorac Surg. 2008 Oct;34(4):850-6. doi: 10.1016/j.ejcts.2008.05.049. Epub 2008 Jul 21.

PMID:
18640847
14.

Epac-Rap1-activated mesenchymal stem cells improve cardiac function in rat model of myocardial infarction.

Khan I, Ali A, Akhter MA, Naeem N, Chotani MA, Iqbal H, Kabir N, Atiq M, Salim A.

Cardiovasc Ther. 2017 Apr;35(2). doi: 10.1111/1755-5922.12248.

PMID:
28039940
15.

MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction.

Chen Y, Zhao Y, Chen W, Xie L, Zhao ZA, Yang J, Chen Y, Lei W, Shen Z.

Stem Cell Res Ther. 2017 Nov 25;8(1):268. doi: 10.1186/s13287-017-0722-z.

16.

C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.

Bao L, Meng Q, Li Y, Deng S, Yu Z, Liu Z, Zhang L, Fan H.

J Card Fail. 2017 May;23(5):403-415. doi: 10.1016/j.cardfail.2017.03.002. Epub 2017 Mar 8.

PMID:
28284757
18.

Protein kinase G1 α overexpression increases stem cell survival and cardiac function after myocardial infarction.

Wang L, Pasha Z, Wang S, Li N, Feng Y, Lu G, Millard RW, Ashraf M.

PLoS One. 2013;8(3):e60087. doi: 10.1371/journal.pone.0060087. Epub 2013 Mar 25.

19.

Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.

Suresh SC, Selvaraju V, Thirunavukkarasu M, Goldman JW, Husain A, Alexander Palesty J, Sanchez JA, McFadden DW, Maulik N.

Int J Cardiol. 2015 Dec 15;201:517-28. doi: 10.1016/j.ijcard.2015.08.117. Epub 2015 Aug 15.

PMID:
26322599
20.

Supplemental Content

Support Center